Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Werner Scheithauer

Showing results (21-30 of 84) with videos related to

Pageof 9
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancerBrigit Gruenberger, Dietmar Tamandl, Johannes Schueller, et al.
Anticancer Research|July 2, 2014
Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumabAndre Farkouh, Werner Scheithauer, Philipp Buchner, et al.
Anti-Cancer Drugs|August 24, 2006
Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse eventCatharina Wenzel, Eleonora Urbauer, Christoph Schwarz, et al.
Oncotargets and Therapy|February 17, 2017
<i>nab</i>-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trialJosep Tabernero, Volker Kunzmann, Werner Scheithauer, et al.
Journal of Clinical Medicine|March 4, 2020
Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer PatientsMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Anti-Cancer Drugs|September 1, 2007
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysisLaurenz Vormittag, Gabriela V Kornek, Barbara Gruhsmann, et al.
Haematologica|April 16, 2013
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyBoris Dickmann, Jonas Ahlbrecht, Cihan Ay, et al.
Anti-Cancer Drugs|February 6, 2003
Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignanciesCatharina Wenzel, Robert M Mader, Guenther G Steger, et al.
Anti-Cancer Drugs|June 5, 2002
Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignanciesClaudia Gedlicka, Birgit Schüll, Michael Formanek, et al.
Clinical Colorectal Cancer|July 26, 2018
Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and RegorafenibMatthias Unseld, Magdalena Drimmel, Alexander Siebenhüner, et al.
Pageof 9

Showing results (21-30 of 84) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancerBrigit Gruenberger, Dietmar Tamandl, Johannes Schueller, et al.
Anticancer Research|July 2, 2014
Clinical pharmacokinetics of capecitabine and its metabolites in combination with the monoclonal antibody bevacizumabAndre Farkouh, Werner Scheithauer, Philipp Buchner, et al.
Anti-Cancer Drugs|August 24, 2006
Severe enteropathy associated with raltitrexed and oxaliplatin chemotherapy: report of two patients experiencing this rare, potentially lethal gastrointestinal adverse eventCatharina Wenzel, Eleonora Urbauer, Christoph Schwarz, et al.
Oncotargets and Therapy|February 17, 2017
<i>nab</i>-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trialJosep Tabernero, Volker Kunzmann, Werner Scheithauer, et al.
Journal of Clinical Medicine|March 4, 2020
Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer PatientsMarkus Kieler, Matthias Unseld, Daniela Bianconi, et al.
Anti-Cancer Drugs|September 1, 2007
UFT/leucovorin and mitomycin C as salvage treatment in patients with advanced colorectal cancer - a retrospective analysisLaurenz Vormittag, Gabriela V Kornek, Barbara Gruhsmann, et al.
Haematologica|April 16, 2013
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis StudyBoris Dickmann, Jonas Ahlbrecht, Cihan Ay, et al.
Anti-Cancer Drugs|February 6, 2003
Capecitabine treatment results in increased mean corpuscular volume of red blood cells in patients with advanced solid malignanciesCatharina Wenzel, Robert M Mader, Guenther G Steger, et al.
Anti-Cancer Drugs|June 5, 2002
Mitoxantrone and cisplatin in recurrent and/or metastatic salivary gland malignanciesClaudia Gedlicka, Birgit Schüll, Michael Formanek, et al.
Clinical Colorectal Cancer|July 26, 2018
Optimizing Treatment Sequence for Late-line Metastatic Colorectal Cancer Patients Using Trifluridine/Tipiracil and RegorafenibMatthias Unseld, Magdalena Drimmel, Alexander Siebenhüner, et al.
Pageof 9